These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9748080)

  • 1. Insulin, diabetes mellitus, Alzheimer's disease, and apolipoprotein E.
    Gambassi G; Bernabei R
    Neurology; 1998 Sep; 51(3):925-6. PubMed ID: 9748080
    [No Abstract]   [Full Text] [Related]  

  • 2. Head circumference and incident Alzheimer's disease: modification by apolipoprotein E.
    Gurwitz D; Chapman J; Weizman A
    Neurology; 2002 May; 58(9):1440. PubMed ID: 12011307
    [No Abstract]   [Full Text] [Related]  

  • 3. Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype.
    Craft S; Peskind E; Schwartz MW; Schellenberg GD; Raskind M; Porte D
    Neurology; 1998 Jan; 50(1):164-8. PubMed ID: 9443474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impairment of insulin signaling in Alzheimer's disease.
    Candeias E; Duarte AI; Carvalho C; Correia SC; Cardoso S; Santos RX; Plácido AI; Perry G; Moreira PI
    IUBMB Life; 2012 Dec; 64(12):951-7. PubMed ID: 23129399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E and Alzheimer's disease.
    Strittmatter WJ
    Ann N Y Acad Sci; 2000; 924():91-2. PubMed ID: 11193808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired insulin signaling and the pathogenesis of Alzheimer's disease.
    Revill P; Moral MA; Prous JR
    Drugs Today (Barc); 2006 Dec; 42(12):785-90. PubMed ID: 17285151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does insulin dysfunction play a role in Alzheimer's disease?
    Gasparini L; Netzer WJ; Greengard P; Xu H
    Trends Pharmacol Sci; 2002 Jun; 23(6):288-93. PubMed ID: 12084635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain insulin resistance may exacerbate Alzheimer's progression. Researchers call it "Type III" diabetes.
    Duke Med Health News; 2012 Sep; 18(9):4-5. PubMed ID: 23029691
    [No Abstract]   [Full Text] [Related]  

  • 9. [Alzheimer's disease and apolipoprotein E].
    Yamaguchi H
    No To Shinkei; 1996 Nov; 48(11):981-90. PubMed ID: 8951889
    [No Abstract]   [Full Text] [Related]  

  • 10. Alzheimer's disease. Risky apolipoprotein in brain.
    Goedert M; Strittmatter WJ; Roses AD
    Nature; 1994 Nov; 372(6501):45-6. PubMed ID: 7969418
    [No Abstract]   [Full Text] [Related]  

  • 11. Alzheimer's disease and diabetes: an integrative view of the role of mitochondria, oxidative stress, and insulin.
    Moreira PI
    J Alzheimers Dis; 2012; 30 Suppl 2():S199-215. PubMed ID: 22269163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose, insulin and the brain: modulation of cognition and synaptic plasticity in health and disease: a preface.
    Biessels GJ; Bravenboer B; Gispen WH
    Eur J Pharmacol; 2004 Apr; 490(1-3):1-4. PubMed ID: 15094068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin and Alzheimer's disease: an amyloid connection.
    Galasko D
    Neurology; 2003 Jun; 60(12):1886-7. PubMed ID: 12821727
    [No Abstract]   [Full Text] [Related]  

  • 14. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.
    Reiman EM; Caselli RJ; Yun LS; Chen K; Bandy D; Minoshima S; Thibodeau SN; Osborne D
    N Engl J Med; 1996 Mar; 334(12):752-8. PubMed ID: 8592548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-1 beta: a common cause of Alzheimer's disease and diabetes mellitus.
    Holden RJ; Mooney PA
    Med Hypotheses; 1995 Dec; 45(6):559-71. PubMed ID: 8771051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin metabolism in Alzheimer's disease differs according to apolipoprotein E genotype and gender.
    Craft S; Asthana S; Schellenberg G; Cherrier M; Baker LD; Newcomer J; Plymate S; Latendresse S; Petrova A; Raskind M; Peskind E; Lofgreen C; Grimwood K
    Neuroendocrinology; 1999 Aug; 70(2):146-52. PubMed ID: 10461029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention.
    Keeney JT; Ibrahimi S; Zhao L
    J Alzheimers Dis; 2015; 48(2):411-24. PubMed ID: 26402005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study.
    Kuusisto J; Koivisto K; Mykkänen L; Helkala EL; Vanhanen M; Hänninen T; Kervinen K; Kesäniemi YA; Riekkinen PJ; Laakso M
    BMJ; 1997 Oct; 315(7115):1045-9. PubMed ID: 9366728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the APOE promoter polymorphisms on cerebral amyloid peptide deposition in Alzheimer's disease.
    Lambert JC; Mann D; Goumidi L; Harris J; Amouyel P; Iwatsubo T; Lendon C; Chartier-Harlin MC
    Lancet; 2001 Feb; 357(9256):608-9. PubMed ID: 11558492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E is a relevant susceptibility gene that affects the rate of expression of Alzheimer's disease.
    Roses AD
    Neurobiol Aging; 1994; 15 Suppl 2():S165-7. PubMed ID: 7700444
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.